28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3069134/0/en/ImPact-Biotech-Presents-Updated-Efficacy-Data-from-Evaluation-of-Padeliporfin-VTP-in-LG-UTUC-and-Intermediate-Risk-Prostate-Cancer-at-AUA-2025.html
11 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/11/3060047/0/en/ImPact-Biotech-Announces-New-Data-Presentations-at-AUA-2025-Highlighting-Safety-and-Efficacy-of-Padeliporfin-VTP.html
27 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/27/2954460/0/en/ImPact-Biotech-Announces-50-Enrollment-in-Phase-3-ENLIGHTED-Clinical-Trial-of-Padeliporfin-VTP-in-Low-Grade-Upper-Tract-Urothelial-Cancer.html
02 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/02/2891848/0/en/ImPact-Biotech-Presents-Additional-Interim-Data-from-ENLIGHTED-Study-of-Padeliporfin-VTP-in-Low-Grade-Upper-Tract-Urothelial-Cancer.html
06 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/06/2875744/0/en/ImPact-Biotech-Presents-Preliminary-Phase-3-Results-from-ENLIGHTED-Study-of-Padeliporfin-VTP-in-Low-Grade-Upper-Tract-Urothelial-Cancer.html
24 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/24/2868734/0/en/ImPact-Biotech-to-Present-Interim-Phase-3-Data-from-ENLIGHTED-Study-of-Padeliporfin-VTP-in-Low-Grade-UTUC-at-Upcoming-Medical-Conferences.html